Is tadalafil an ACE inhibitor? This is a common question among patients prescribed tadalafil for erectile dysfunction or benign prostatic hyperplasia. The short answer is no—tadalafil is not an ACE inhibitor. Tadalafil belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which work by enhancing blood flow in response to sexual stimulation. ACE inhibitors, by contrast, are medications used to treat high blood pressure, heart failure, and kidney disease by blocking a specific enzyme in the cardiovascular system. Understanding the differences between these two drug classes is important for safe and effective treatment.

What Is Tadalafil and How Does It Work?

Tadalafil is a prescription medication primarily used to treat erectile dysfunction (ED) and the symptoms of benign prostatic hyperplasia (BPH). It belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors. Tadalafil is not an ACE inhibitor and works through an entirely different mechanism within the body.

The drug functions by selectively inhibiting the PDE5 enzyme, which is highly expressed in the corpus cavernosum (erectile tissue) and pulmonary vasculature, but also present in other tissues. Under normal circumstances, sexual stimulation triggers the release of nitric oxide in penile tissue, which activates an enzyme called guanylate cyclase. This enzyme increases levels of cyclic guanosine monophosphate (cGMP), a chemical messenger that relaxes smooth muscle and dilates blood vessels, allowing increased blood flow necessary for an erection.

PDE5 normally breaks down cGMP, limiting the duration of this vasodilatory effect. By inhibiting PDE5, tadalafil allows cGMP to accumulate, thereby prolonging smooth muscle relaxation and enhancing blood flow to the penis during sexual arousal. This mechanism makes tadalafil effective for erectile dysfunction, but it requires sexual stimulation to work—it does not cause spontaneous erections.

Tadalafil is also licensed for treating pulmonary arterial hypertension (under the brand name Adcirca, typically at a dose of 40mg once daily) because the same mechanism improves blood flow in the pulmonary circulation. Common brand names in the UK include Cialis for ED and BPH. The medication is available in various doses (2.5mg, 5mg, 10mg, and 20mg) and can be taken as needed or daily, depending on the indication and prescribing guidance.

Tadalafil produces small, generally clinically insignificant reductions in blood pressure in most patients. It must not be used with nitrates or guanylate cyclase stimulators (e.g., riociguat) due to the risk of severe hypotension. Caution is also needed when used with alpha-blockers; patients should be stable on alpha-blocker therapy before starting tadalafil, and the lowest dose should be initiated.

What Are ACE Inhibitors and Their Mechanism of Action?

Angiotensin-converting enzyme (ACE) inhibitors are a well-established class of medications used primarily to treat hypertension (high blood pressure), heart failure, and chronic kidney disease. Common examples available in the UK include ramipril, lisinopril, enalapril, and perindopril. These drugs work by targeting the renin-angiotensin-aldosterone system (RAAS), a hormonal cascade that regulates blood pressure and fluid balance.

The mechanism of ACE inhibitors centres on blocking the angiotensin-converting enzyme, which is responsible for converting angiotensin I (an inactive precursor) into angiotensin II (a potent vasoconstrictor). Angiotensin II causes blood vessels to narrow, raises blood pressure, and stimulates the release of aldosterone, a hormone that promotes sodium and water retention by the kidneys. By inhibiting this conversion, ACE inhibitors reduce levels of angiotensin II, leading to vasodilation (widening of blood vessels), decreased blood pressure, and reduced strain on the heart.

Additionally, ACE inhibitors reduce the breakdown of bradykinin, a peptide that promotes vasodilation. This contributes to their blood pressure-lowering effect but is also responsible for one of the most common adverse effects: a persistent dry cough, which affects approximately 10–15% of patients. Other potential side effects include hyperkalaemia (elevated potassium levels), dizziness, fatigue, and, rarely, angioedema (swelling of the face, lips, or throat).

According to NICE guidance (NG136), ACE inhibitors or angiotensin receptor blockers (ARBs) are recommended as first-line treatment for hypertension in adults under 55 years of age and for all adults with type 2 diabetes. For people aged 55 and over or of African or Caribbean family origin without diabetes, calcium channel blockers are recommended first-line. ACE inhibitors are also integral in managing heart failure and protecting kidney function in diabetic nephropathy.

ACE inhibitors are contraindicated in pregnancy and require monitoring of kidney function and potassium levels 1-2 weeks after starting treatment or increasing the dose. They can interact with potassium supplements, potassium-sparing diuretics, NSAIDs, and lithium. Unlike tadalafil, ACE inhibitors are specifically designed to modulate cardiovascular and renal physiology for long-term disease management.

Key Differences Between Tadalafil and ACE Inhibitors

Tadalafil and ACE inhibitors are fundamentally different medications with distinct therapeutic purposes, mechanisms of action, and clinical applications. Tadalafil is not an ACE inhibitor, and the two drug classes should not be confused despite both having some effect on blood vessels.

Mechanism of action is the primary distinction. Tadalafil works by inhibiting the PDE5 enzyme, which increases cGMP levels and promotes vasodilation specifically in response to nitric oxide release during sexual stimulation or in pulmonary vessels. ACE inhibitors, conversely, block the conversion of angiotensin I to angiotensin II, thereby reducing systemic vasoconstriction and aldosterone secretion. These are entirely separate biochemical pathways.

Therapeutic indications also differ markedly. Tadalafil is prescribed for erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. ACE inhibitors are used to manage hypertension, heart failure, post-myocardial infarction care, and diabetic kidney disease. While tadalafil may cause small, generally clinically insignificant reductions in blood pressure in most patients, it is not indicated or effective as an antihypertensive agent.

Side effect profiles further differentiate these medications. Tadalafil commonly causes headache, flushing, nasal congestion, dyspepsia, and back pain. Serious adverse effects are rare but include priapism (prolonged erection lasting more than 4 hours, requiring urgent medical attention) and sudden vision or hearing loss (also requiring immediate medical care). ACE inhibitors frequently cause dry cough, dizziness, hyperkalaemia, and carry a risk of angioedema and renal impairment, particularly in patients with renal artery stenosis.

Drug interactions are another important consideration. Tadalafil is contraindicated with nitrates (e.g., glyceryl trinitrate) and should not be used within at least 48 hours of taking tadalafil. It is also contraindicated with guanylate cyclase stimulators such as riociguat. Caution is needed when using tadalafil with alpha-blockers due to potential additive blood pressure-lowering effects. ACE inhibitors interact with potassium supplements, potassium-sparing diuretics, NSAIDs, and lithium. Patients taking both tadalafil and ACE inhibitors concurrently should be monitored for additive blood pressure-lowering effects, though this combination is not contraindicated and is commonly prescribed safely under medical supervision.

When to Speak with Your GP About Blood Pressure Medications

Understanding when to consult your GP regarding blood pressure medications is essential for maintaining cardiovascular health and ensuring safe, effective treatment. If you are taking tadalafil and have concerns about blood pressure or are considering starting an ACE inhibitor (or vice versa), professional medical guidance is crucial.

You should contact your GP if:

• You experience symptoms of low blood pressure (hypotension) such as persistent dizziness, light-headedness, fainting, blurred vision, or unusual fatigue, particularly if you are taking tadalafil alongside antihypertensive medications.

• You develop new or worsening symptoms while on ACE inhibitors, including a persistent dry cough, swelling of the face or throat (which may indicate angioedema and requires emergency care—call 999 or attend A&E), or signs of elevated potassium such as muscle weakness or irregular heartbeat.

• You are prescribed tadalafil and are already taking medications for high blood pressure, heart disease, or chest pain. Do not take tadalafil with nitrates or riociguat under any circumstances. If chest pain occurs after taking tadalafil, seek urgent medical help and do not self-administer nitrates.

• You have been diagnosed with hypertension and are uncertain whether your current treatment is adequate, or if you are experiencing side effects that affect your quality of life.

• You are considering over-the-counter medications or supplements that might interact with your prescribed treatments, such as NSAIDs, potassium supplements, or herbal remedies.

• You experience a prolonged erection lasting more than 4 hours (priapism) or sudden loss of vision or hearing after taking tadalafil—these require urgent medical attention.

Once your blood pressure is controlled and treatment is stable, you should have at least an annual review with your GP. More frequent checks may be needed if treatment changes or concerns arise. If you start or increase the dose of an ACE inhibitor, your kidney function and potassium levels should be checked after 1-2 weeks, and periodically thereafter.

Never stop or adjust your blood pressure medications without medical advice, as abrupt discontinuation can lead to rebound hypertension or worsening of underlying conditions. If you experience side effects from any medication, you can report them through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or the Yellow Card app). Open communication with your healthcare team ensures that your treatment remains safe, effective, and tailored to your individual needs.

Frequently Asked Questions